bluebird bio, Inc. (NASDAQ:BLUE) Receives Consensus Recommendation of “Hold” from Brokerages
Shares of bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) have been assigned an average rating of “Hold” from the eight analysts that are presently covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average twelve-month price […]
Shares of bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) have been assigned an average rating of “Hold” from the eight analysts that are presently covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average twelve-month price […]
